In 2023, the hospital discharges for malignant neoplasm of the skin in Canada were recorded at 2.05 thousand. The forecasted data from 2024 to 2028 shows a gradual increase, reaching 2.1 thousand discharges. This represents a steady year-on-year growth of approximately 0.5%. Over the five-year period, the compound annual growth rate (CAGR) stands at around 0.49%.

Future trends to watch for include:

Potential impacts of public health initiatives aimed at reducing skin cancer rates.
Advancements in medical treatment and technology potentially altering hospitalization rates.
The influence of demographic changes, particularly aging populations, on skin cancer incidences.